Vivos Therapeutics, Inc. (VVOS)

NASDAQ: VVOS · Real-Time Price · USD

1.350

-0.060 (-4.26%)

At close: Mar 3, 2026, 4:00 PM EST

1.300

-0.050 (-3.70%)

After-hours: Mar 3, 2026, 7:25 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Healthcare Facilities & Services	15.03M	13.80M	16.02M	16.89M	13.07M
Healthcare Facilities & Services Growth	8.91%	-13.87%	-5.10%	29.23%	14.68%
Total	15.03M	13.80M	16.02M	16.89M	13.07M
Total Growth	8.91%	-13.87%	-5.10%	29.23%	14.68%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
United States	15.03M	13.80M	16.02M	16.89M	13.07M
United States Growth	8.91%	-13.87%	-5.10%	29.23%	14.68%
Total	15.03M	13.80M	16.02M	16.89M	13.07M
Total Growth	8.91%	-13.87%	-5.10%	29.23%	14.68%

Source: S&P Global Market Intelligence.